P009 “High-risk” patients with aggressive non-Hodgkin lymphoma should benefit from autologous stem cell transplantation in first remission (single-centre experience) - Genadieva Stavrik, S.; Cevreska, L.; Stojanoski, Z.; Pivkova, A.; Stojanovik, A.; Krstevska Balkanov, S.; Karanfilski, O.; Georgievski, B. (Elsevier BV, 2007)